Arteriosclerosis, thrombosis, and vascular biology

01 1 November 2026

DOI 10.1161/atv.0000000000000200

Correction to: Abstract Fri013: The Aortic Inflammation Affects Long-Term Freedom From Reintervention After Aortic Arch Procedures

Open DOI

Luca Zanella, Alice Pozza, Chiara Baldovini et al.

02 15 October 2026

DOI 10.1161/atvbaha.126.325434

Cardiomyocyte-Specific LncRNA CSTPP Prolongs the Proliferation Window by Promoting CDKN1A Decay in Postinfarction Cardiac Regeneration

Open DOI

Ji-Dong Chen, Xi-Yan Lin, Xiao-Lu Yang et al.

BACKGROUND: Adult mammalian cardiomyocytes exhibit some capacity to reenter the cell cycle after ischemic injury. However, activated cardiomyocytes rapidly undergo cell cycle rearrest shortly after activation. Long noncoding RNAs (lncRNA...

Read abstract

03 15 October 2026

DOI 10.1161/atvbaha.126.325404

Magnetic Particle Imaging of Macrophage Phagocytosis Evaluates Plaque Vulnerability and Therapeutic Efficacy in Atherosclerosis

Open DOI

Wei Tong, Ying Han, Yuxing Chen et al.

BACKGROUND: Developing new atherosclerosis therapeutics remains challenging. A noninvasive imaging method to assess plaque vulnerability is needed to provide early efficacy readouts and help select promising candidates for clinical trial...

Read abstract

04 15 October 2026

DOI 10.1161/atvbaha.126.325037

Prior Venous Thromboembolism Defines Distinct Genetic and Molecular Phenotypes in Chronic Thromboembolic Pulmonary Hypertension

Open DOI

Zhu Zhang, Mengjie Duo, Xiaofan Ji et al.

BACKGROUND: Chronic thromboembolic pulmonary hypertension (CTEPH) has traditionally been considered a long-term complication of pulmonary embolism. However, a substantial proportion of patients have no history of venous thromboembolism (...

Read abstract

05 15 October 2026

DOI 10.1161/atvbaha.126.324811

Human Genetics of Adipose Dysfunction: Genomic Mechanisms and Therapeutic Opportunities in Cardiometabolic Disease

Open DOI

Elizabeth A. Burton, Victor Svenstrup, Mayank Murali et al.

Cardiometabolic diseases are a leading cause of global morbidity and mortality and arise from shared and distinct risk factors acting through interconnected biological pathways. Although excess adiposity is a major risk factor, body mass...

Read abstract

06 15 October 2026

DOI 10.1161/atvbaha.126.324762

AI and Deep Learning in Cardiovascular Imaging: From Risk Stratification to Precision Phenotyping

Open DOI

Kaiyue Diao, Jiahua Lu, Alexander Dimitrakakis et al.

Cardiovascular imaging plays a central role in the diagnosis, risk stratification, and management of cardiovascular disease, yet the complexity and volume of imaging data increasingly exceed the capacity of conventional interpretation. A...

Read abstract

07 8 October 2026

DOI 10.1161/atvbaha.126.325420

Short-Term Dietary Exposures and Thrombin Generation in Tanzanian Men: Exploratory Coagulation-Focused Analysis of a Randomized Dietary-Switch Trial

Open DOI

Eka Patricia Kisali, Mark Roest, Tal Pecht et al.

BACKGROUND: Rapid dietary transitions in sub-Saharan Africa may alter coagulation profiles; however, this remains poorly characterized. METHODS: An open-label dietary-intervention trial in Tanzania enrolled 77 healthy men aged 20 to 40 y...

Read abstract

08 8 October 2026

DOI 10.1161/atvbaha.126.324094

LncRNA TAAL Regulates TIE1-Mediated Vascular Remodeling and Is Associated With Diabetic Retinopathy

Open DOI

Gyan Ranjan, Samriddhi Arora, Sarmeela Sharma et al.

BACKGROUND: TIE1 is an endothelial receptor tyrosine kinase, which plays a crucial role in vascular development and remodeling, including in diseases such as diabetic retinopathy (DR). However, the molecular mechanisms and regulatory int...

Read abstract

09 8 October 2026

DOI 10.1161/atvbaha.126.324766

Wearable Sensors and Remote Patient Monitoring in Cardiovascular Disease: From Continuous Physiological Surveillance to Actionable Insights

Open DOI

Ahmed Tariq, Wonbum Sohn, Yoon Jae Lee et al.

Wearable technologies are increasingly used to support cardiovascular care by enabling continuous physiological monitoring beyond conventional clinical environments. Advances in consumer and medical-grade devices have expanded cardiovasc...

Read abstract

10 1 October 2026

DOI 10.1161/atvbaha.126.325001

Hypermetabolic State Drives Platelet Dysfunction in Human and Mouse Metabolic Dysfunction-Associated Steatotic Liver Disease

Open DOI

Francesca Maiorca, Annamaria Sabetta, Moris Sangineto et al.

BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing health concern given rising global prevalence, limited diagnostic and therapeutic tools, and strong association with cardiovascular disease. Platel...

Read abstract